Chu‐Shu Gu
About
Chu‐Shu Gu is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Internal Medicine.
According to data from OpenAlex, Chu‐Shu Gu has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Internal Medicine. Recurrent topics in Chu‐Shu Gu's work include Radiomics and Machine Learning in Medical Imaging (12 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (10 papers). Chu‐Shu Gu is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (12 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (10 papers). Chu‐Shu Gu collaborates with scholars based in Canada, United States and France. Chu‐Shu Gu's co-authors include Jim A. Julian, Mark N. Levine, Gregory J. Butler, Agnes Lee, Carolyn Webb, Lorrie Costantini, Howard A. Liebman, Susan Solymoss, Luz M. Ramirez and David Deitchman and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.
In The Last Decade
Chu‐Shu Gu
35 papers receiving 972 citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Chu‐Shu Gu Canada | 12 | 569 | 375 | 324 | 290 | 250 | 36 | 1.0k | ||
| Sandro Morassut Italy | 18 | 234 0.4× | 269 0.7× | 225 0.7× | 639 2.2× | 103 0.4× | 40 | 1.3k | ||
| Marianne Sinn Germany | 12 | 263 0.5× | 139 0.4× | 208 0.6× | 195 0.7× | 174 0.7× | 34 | 807 | ||
| Oliver Königsbrügge Austria | 20 | 643 1.1× | 137 0.4× | 163 0.5× | 116 0.4× | 549 2.2× | 52 | 1.2k | ||
| F. Nowakowski United States | 17 | 169 0.3× | 136 0.4× | 393 1.2× | 643 2.2× | 127 0.5× | 71 | 1.0k | ||
| Frits I. Mulder Netherlands | 12 | 805 1.4× | 272 0.7× | 154 0.5× | 81 0.3× | 523 2.1× | 31 | 1.0k | ||
| J.F. Timp Netherlands | 8 | 803 1.4× | 196 0.5× | 189 0.6× | 98 0.3× | 509 2.0× | 15 | 1.0k | ||
| Kristen M. Sanfilippo United States | 19 | 477 0.8× | 94 0.3× | 188 0.6× | 158 0.5× | 288 1.2× | 101 | 1.2k | ||
| Gualberto Gussoni Italy | 12 | 1.4k 2.4× | 512 1.4× | 279 0.9× | 95 0.3× | 1.0k 4.2× | 17 | 1.5k | ||
| Sun Young Choi South Korea | 17 | 111 0.2× | 116 0.3× | 569 1.8× | 375 1.3× | 68 0.3× | 52 | 1.0k | ||
| H. R. Büller Netherlands | 13 | 592 1.0× | 173 0.5× | 285 0.9× | 62 0.2× | 370 1.5× | 23 | 833 |
Countries citing papers authored by Chu‐Shu Gu
Since
Specialization
Citations
This map shows the geographic impact of Chu‐Shu Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chu‐Shu Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chu‐Shu Gu more than expected).
Fields of papers citing papers by Chu‐Shu Gu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Chu‐Shu Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chu‐Shu Gu. The network helps show where Chu‐Shu Gu may publish in the future.
Co-authorship network of co-authors of Chu‐Shu Gu
This figure shows the co-authorship network connecting the top 25 collaborators of Chu‐Shu Gu. A scholar is included among the top collaborators of Chu‐Shu Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chu‐Shu Gu. Chu‐Shu Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Gu, Chu‐Shu, et al.. (2025). The Effect of Thrombolysis of Deep Vein Thrombosis on Late Symptoms of Post–Pulmonary Embolism Syndrome. Journal of Vascular and Interventional Radiology. 36(6). 1026–1030.
2.
Gu, Chu‐Shu, et al.. (2023). Exploring the Villalta scale to capture postthrombotic syndrome using alternative approaches: A subanalysis of the ATTRACT trial. Research and Practice in Thrombosis and Haemostasis. 7(1). 100032–100032.
3.
Gu, Chu‐Shu, et al.. (2022). New and known predictors of the postthrombotic syndrome: A subanalysis of the ATTRACT trial. Research and Practice in Thrombosis and Haemostasis. 6(6). e12796–e12796.
4.
Lee, Amanda, Chu‐Shu Gu, Suresh Vedantham, et al.. (2021). Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome. Journal of Vascular Surgery Venous and Lymphatic Disorders. 9(5). 1257–1265.e2.
5.
Comerota, Anthony J., Clive Kearon, Chu‐Shu Gu, et al.. (2020). Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis. Journal of Vascular Surgery Venous and Lymphatic Disorders. 8(2). 306–307.
6.
Rabinovich, Anat, Chu‐Shu Gu, Suresh Vedantham, et al.. (2020). External validation of the SOX‐PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis. Journal of Thrombosis and Haemostasis. 18(6). 1381–1389.
7.
Kearon, Clive, Marc Carrier, Chu‐Shu Gu, et al.. (2020). Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial. Seminars in Thrombosis and Hemostasis. 46(8). 977–985.
8.
Wang, Julian, Marko Šimunović, Sameer Parpia, et al.. (2020). Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cost analysis in Ontario, Canada - Health economic evaluation. International Journal of Surgery. 78. 75–82.
9.
Comerota, Anthony J., Clive Kearon, Chu‐Shu Gu, et al.. (2019). Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis. Circulation. 139(9). 1162–1173.
10.
Gu, Chu‐Shu, et al.. (2016). Isolation and characterization of the Chrysanthemum nitrate transporter CmNRT1. Genetics and Molecular Research. 15(1).
11.
Elit, L., Anthony Fyles, Chu‐Shu Gu, et al.. (2015). The role of PET-CT in treatment decision making for women with locally advanced cervical cancer.. Journal of Clinical Oncology. 33(15_suppl). 5523–5523.
12.
Parpia, Sameer, Jim A. Julian, Lehana Thabane, et al.. (2014). Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer. BMJ Open. 4(10). e006531–e006531.
13.
Parpia, Sameer, Jim A. Julian, Chu‐Shu Gu, Lehana Thabane, & Mark N. Levine. (2014). Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified times. SpringerPlus. 3(1). 323–323.
14.
Levine, Mark N., Chu‐Shu Gu, Howard A. Liebman, et al.. (2012). A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. Journal of Thrombosis and Haemostasis. 10(5). 807–814.
15.
Darling, Gail, Donna E. Maziak, Richard Inculet, et al.. (2011). Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial. Journal of Thoracic Oncology. 6(8). 1367–1372.
16.
Ung, Yee, Chu‐Shu Gu, A. Sun, et al.. (2011). An Ontario Clinical Oncology (OCOG) Randomized Trial (PET START) of FDG PET/CT in Stage 3 Non-small Cell Lung Cancer (NSCLC): Impact of PET on Survival. International Journal of Radiation Oncology*Biology*Physics. 81(2). S137–S137.
17.
Gu, Chu‐Shu, A. Sun, Robert M. MacRae, et al.. (2011). An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.. Journal of Clinical Oncology. 29(15_suppl). 7018–7018.
18.
Levine, Mark N., Leyo Ruo, Chu‐Shu Gu, et al.. (2011). An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM).. Journal of Clinical Oncology. 29(15_suppl). 3520–3520.
19.
Elit, Laurie, Mark N. Levine, Jim A. Julian, et al.. (2010). Expectant management versus immediate treatment for low‐grade cervical intraepithelial neoplasia. Cancer. 117(7). 1438–1445.
20.
Lee, Agnes, Mark N. Levine, Gregory J. Butler, et al.. (2006). Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer. Journal of Clinical Oncology. 24(9). 1404–1408.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sandro Morassut Breakdown of academic impact, for papers by Marianne Sinn Breakdown of academic impact, for papers by Oliver Königsbrügge Breakdown of academic impact, for papers by F. Nowakowski Breakdown of academic impact, for papers by Frits I. Mulder Breakdown of academic impact, for papers by J.F. Timp Breakdown of academic impact, for papers by Kristen M. Sanfilippo Breakdown of academic impact, for papers by Gualberto Gussoni Breakdown of academic impact, for papers by Sun Young Choi Breakdown of academic impact, for papers by H. R. Büller